INDIAN BENCHMARK have turned flat after making a higher opening post Infosys appointed former SAP executive Vishal Sikka as the CEO and MD of the company. IIP and CPI data will be in focus today.
FURTHER, Ranbaxy Laboratories had filed applications seeking to sell drugs in the US made at its Gurgaon plant, which is not on among those barred by the US Food and Drug Administration. Shares of tea manufacturing companies have seen smart rally on hopes of an upsurge in tea prices amid low productivity.
Trend in FII flows: The FIIs were net buyers of Rs 192cr in the cash segment on Wednesday while the DIIs were net sellers of Rs. 407cr, as per the provisional figures released by the NSE.
FURTHER, Ranbaxy Laboratories had filed applications seeking to sell drugs in the US made at its Gurgaon plant, which is not on among those barred by the US Food and Drug Administration. Shares of tea manufacturing companies have seen smart rally on hopes of an upsurge in tea prices amid low productivity.
Trend in FII flows: The FIIs were net buyers of Rs 192cr in the cash segment on Wednesday while the DIIs were net sellers of Rs. 407cr, as per the provisional figures released by the NSE.
For More Detail Call Us 0731-6790000,6669900
Click Here capitalstars.com
Click Here capitalstars.com
0 Comments